Picture of Genmab A/S logo

GMAB Genmab A/S Cashflow Statement

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for Genmab A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,9043,9837,0355,6379,164
Depreciation
Amortisation
Non-Cash Items609-687-239270-1,625
Unusual Items
Other Non-Cash Items
Changes in Working Capital-339-1,316-3,2461,178-181
Change in Accounts Receivable
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities6,4332,2283,9127,3807,771
Capital Expenditures-307-252-317-376-304
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-2,044-709-2,444-906-9,603
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-2,351-961-2,761-1,282-9,907
Financing Cash Flow Items-25-50-88-103-109
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities71-420-789-606-3,919
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3,7081,6979364,974-5,009